Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing ’s syndrome

ConclusionsTreatment with levoketoconazole was associated with sustained, meaningful improvements in QoL, depression, and certain clinical signs and symptoms characteristic of CS.ClinialTrials.gov identifier: NCT01838551.
Source: Pituitary - Category: Endocrinology Source Type: research